When was Explora BioLabs founded?

Explora BioLabs was founded in 2004.

Where is Explora BioLabs located?

Explora BioLabs is headquartered in San Diego, United States.

Who is the current CEO of Explora BioLabs?

Richard Lin of Explora BioLabs. They are also an angel investors in 1 startup.

How many employees does Explora BioLabs have?

As of Mar 01, 2026, the latest employee count at Explora BioLabs is 10 - 49.

Is Explora BioLabs a funded company?

Explora BioLabs is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round.

When was the latest funding round of Explora BioLabs?

Explora BioLabs' latest funding was a $***** Series A round, with participation from 0 investor.

Where does Explora BioLabs rank among its competitors?

Explora BioLabs ranks 230th amongst 2063 active competitors, of which 462 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Explora BioLabs?

Explora BioLabs' top competitors include Synthego, Antheia and Transcenta. Among them, Antheia secured the most recent funding round in January, 2026.

Explora BioLabs - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of discovery pharmacology and vivarium services for biotechnology and pharmaceutical clients. The company offers vivarium-as-a-service and contract research solutions for biotechnology and pharmaceutical companies.

Website: explorabiolabs.com
Social

Key Metrics

Founded Year

2004

Location

San Diego, United States

Stage

Acquired

Latest Funding Round

Series A, $*****

Investors

Milk Street Ventures & 3 more

Ranked

230^th among 2063 active competitors

Employee Count

10 - 49 as on Mar 01, 2026

Similar Companies

Synthego & 2665 more

Exit Details

Acquired by Charles River Laboratories (Apr 06, 2022)

View Explora BioLabs' full profile

Explora BioLabs is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Charles River Laboratories International, Inc CIN: 2375407 , United States, Active	Feb 03, 1994	-	-	-

Explora BioLabs got acquired by Charles River Laboratories on Apr 06, 2022 at an acquisition amount of $*****.

Click here to take a look at Explora BioLabs's acquisition in detail

Explora BioLabs has raised funding over 1 round. Explora BioLabs has 4 institutional investors.

View details of Explora BioLabs's funding rounds and investors

The founders of Explora BioLabs is Richard Lin.

Here are the details of Explora BioLabs' key team members:

Richard Lin: CEO and Founder of Explora BioLabs and founder of 1 other company. They are also an angel investor in 1 startup.

View details of Explora BioLabs's Founder profiles and Board Members

Explora BioLabs' employee count trend

Explora BioLabs has 10 - 49 employees as of Mar 26. Here is Explora BioLabs's employee count trend over the years:

Employee count trend for Explora BioLabs

Uncover Explora BioLabs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Explora BioLabs include Synthego, Antheia and Transcenta. Here is the list of Top 10 competitors of Explora BioLabs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, RA Capital Management & 30 others	71/100
2nd	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
3rd	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
4th	Judges Scientific 2002, London (United Kingdom), Public	Acquisition and development of scientific instrument businesses	-	Origin Capital, Lloyds Banking Group	65/100
5th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Sino Biopharmaceutical, Orbimed & 18 others	65/100
6th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Fidelity Investments, Verition Fund Management ... & 14 others	64/100
7th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Smalt Capital & 14 others	63/100
8th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	UBS, Brown Brothers Harriman & 1 others	63/100
9th	Dewpoint Therapeutics 2018, Boston (United States), Series D	Developer of small molecule based therapeutics	$346M	Maverick Ventures, Polaris Partners & 16 others	62/100
10th	One Biosciences 2020, Paris (France), Series A	Developer of single-cell therapeutics solutions to treat multiple health disorders	$22.4M	BLAST Premier, Redmile Group & 6 others	62/100
230th	Explora BioLabs 2004, San Diego (United States), Acquired	Provider of discovery pharmacology and vivarium services for biotechnology and pharmaceutical clients	-	Milk Street Ventures, Aspect Investors & 2 others	42/100